Ingmar Gorman, PhD

Ingmar Gorman, PhD is a New York–licensed clinical psychologist who offers psychedelic integration therapy and trauma therapy by telehealth, in English and Czech.

I work with adults navigating trauma, anxiety, depression, substance use, and their relationship with psychedelics, as well as business leaders, expats, and people from Czech, Slovak, and Eastern European backgrounds building a life between cultures.

My life has moved between cultures: American and Czech, New York and Europe. Understanding the liminal, finding the in-between places, and honoring our capacity for healing is what drew me to psychotherapy. In sessions I'm curious, direct, and allow for your process to unfold. I care less about fitting you into a method than about understanding how your particular life came to feel the way it does.

I've spent nearly twenty years in psychedelic therapy as a clinician, researcher, and trainer, and I bring that experience into the room alongside a grounding in evidence-based psychotherapy. Book a free 30-minute consultation.

Clinical research

• MDMA-assisted therapy for PTSD. I was site co-principal investigator and a study therapist on the Phase 2 and Phase 3 trials of MDMA-assisted therapy for PTSD in New York, sponsored by Resilient Pharmaceuticals (formerly MAPS PBC and Lykos Therapeutics). I'm a co-author of the Phase 3 results published in Nature Medicine (2021).

• Psilocybin for depression. I was a study therapist on COMPASS Pathways' Phase 2 trial of psilocybin therapy for treatment-resistant depression at the New York State Psychiatric Institute.

• Posttraumatic growth. I led research on how people grow after MDMA-assisted therapy for PTSD, published in the Journal of Traumatic Stress (2020).

Training and licensure

• PhD in Clinical Psychology, The New School for Social Research (2017)

• Clinical internship at Bellevue Hospital Center, with clinical training at Mount Sinai Beth Israel and Columbia University

• NIH postdoctoral fellowship, Behavioral Sciences Training in Drug Abuse Research, New York University (2017–2019)

• Licensed psychologist, New York State, License #023021

• MAPS MDMA-Assisted Therapy training

Why Czech?

I'm a dual US and Czech citizen and speak Czech fluently. My early research career began at the Prague Psychiatric Center, and I've written about the history of LSD research in the former Czechoslovakia. Many of my Czech and Slovak clients choose to work in their first language, or to move between languages as feels natural.

Psychoterapii nabízím i v češtině. Sezení probíhají online.

Working with me

Sessions are by telehealth for New York State residents and for clients living outside the USA. I'm in network with Aetna; otherwise fees are $200–$400 per session, and I can provide a superbill for out-of-network reimbursement. The first step is a free 30-minute consultation. Contact me.